Influence of peptide conformation on oligosaccharide binding characteristics - A study using apamin-based chimeric peptide

Peptides

Volumn 24, Issue 12, 2003, Pages 1853-1861

  Wu, Cheng Wei ^a   Jayaraman, Gurunathan ^a,b   Chien, Kun Yi ^a   Liu, Yaw Jen ^a   Lyu, Ping Chiang ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b The Voluntary Health Services Chennai   (India)

Author keywords

Binding specificity; Chimeric peptide; Heparin; Peptide conformation; Peptide design

Indexed keywords

APAMIN; BEE VENOM; DISULFIDE; GLOBULAR PROTEIN; LYSINE; OLIGOSACCHARIDE; PEPTIDE; POLYPEPTIDE;

ANALYTIC METHOD; ARTICLE; BINDING AFFINITY; CHIMERA; DISSOCIATION; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN ISOLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; TITRIMETRY;

APIS MELLIFERA; APOIDEA;

EID: 0842287565     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2003.10.004     Document Type: Article

References (36)

1. Aoyama H., Naka D., Yoshiyama Y., Ishii T., Kondo J., Mitsuka M.et al. Isolation and conformational analysis of fragment peptide corresponding to the heparin-binding site of a hepatocyte growth factor. Biochemistry. 36:1997;10286-10291.
2. Aviezer D., Levy E., Safran M., Svahn C., Buddecke E., Schmidt A.et al. Differential requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. J. Biol. Chem. 269:1994;114-121.
3. Blumenkrantz N., Asboe-Hansen G. A new method for quantitative determination of uronic acids. Anal. Biochem. 54:1973;484-489.
4. Booth B.A., Boes M., Andreas D.L., Dake B.C., Kiefer M.C., Maak C.et al. IGFBP-3 and IGFBP-5 association with endothelial cells: role of C-terminal heparin binding domain. Growth Regul. 5:1995;1-17.
5. Callewaert G.L., Shipolini R., Vernon C.A. The disulfide bridges of apamin. FEBS Lett. 1:1968;111-113.
6. Cardin A.D., Weintraub H.J.R. Molecular modeling of protein- glycosaminoglycan interactions. Asteriosclerosis. 9:1989;21-32.
7. Contrad HE. Heparin binding proteins. San Diego, USA: Academic Press; 1989.
8. Faham S., Hileman R.E., Fromm J.R., Linhardt R.J., Rees D.C. Heparin structure and interactions with basic fibroblast growth factor. Science. 271:1996;1116-1120.
9. Faham S., Linhardt R.J., Rees D.C. Diversity does make a difference: fibroblast growth factor-heparin interactions. Curr. Opin. Struct. Biol. 8:1998;578-586.
10. Faller B., Mely Y., Gerard D., Bieth J.G. Heparin-induced conformational change and activation of mucus proteinase inhibitor. Biochemistry. 31:1992;8285-8290.
11. Ferran D.S., Sobel M., Harris R.B. Design and synthesis of a helix heparin-binding peptide. Biochemistry. 31:1992;5010-5016.
12. Feyzi E., Trybala E., Bergstrom T., Lindahl U., Spillman D. Structural requirement of heparan sulfate for interaction with herpes simplex virus type I virions and isolated glycoprotein C. J. Biol. Chem. 272:1997;24850-24857.
13. Fromm J.R., Hileman R.E., Caldwell E.E.O., Weiler J.M., Linhardt R.J. Differences in the interaction of heparin with arginine and lysine and the importance of these basic residues in the binding of the heparin to acidic fibroblast growth factor. Arch. Biochem. Biophys. 323:1995;279-287.
14. Fromm J.R., Hileman R.E., Caldwell E.E.O., Weiler J.M., Linhardt R.J. Pattern and spacing of basic amino acids in heparin binding sites. Arch. Biochem. Biophys. 343:1997;92-100.
15. Fromm J.R., Hileman R.E., Weiler J.M., Linhardt R.J. Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides. Arch. Biochem. Biophys. 346:1997;252-262.
16. Gill S.C., von Hippel P.H. Calculation of protein extinction coefficient from amino acid sequence data. Anal Biochem. 182:1989;319-326.
17. Hari S.P., McAllister H., Chaung W.-L., Christ M.D., Rabenstein D.L. Interaction of heparin with a synthetic decapeptide from the C-terminal heparin-binding domain of fibronectin. Biochemistry. 39:2000;3763-3773.
18. Hileman R.E., Fromm J.R., Weiler J.M., Linhardt R.J. Glycosaminoglycan- protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. Bioessays. 20:1998;156-167.
19. Ishai-Michaeli R., Svahn C.M., Weber M., Chajek-Shaul T., Korner G., Ekre H.P.et al. Importance of size and sulfation of heparin in release of basic fibroblast growth factor from the vascular endothelium and extracellular matrix. Biochemistry. 31:1992;2080-2088.
20. Jayaraman G., Wu C.W., Liu Y.J., Chien K.Y., Fang J.C., Lyu P.C. Binding of a de novo designed peptide to specific glycosaminoglycans. FEBS Lett. 482:2000;154-158.
21. Lane DA, Lindahl U. Heparin, chemical and biological properties, clinical applications. Boca Raton, FL: CRC Press, Inc.; 1989.
22. Linker A., Hovingh P. Isolation and characterization of oligosaccharides obtained from heparin by action of heparinase. Biochemistry. 11:1972;563-568.
23. Lookene A., Stenlund P., Tibell L.A.E. Characterization of heparin binding of human extracellular superoxide dismutase. Biochemistry. 39:2000;230-236.
24. Margalit H., Fischer N., Ben-Sasson S.A. Comparitive analysis of structurally defined heparin binding sequences reveals a distinct spatial distribution of basic residues. J. Biol. Chem. 268:1993;19228-19231.
25. Montserret R., Aubert-Foucher E., McLeish M.J., Hill J.M., Ficheux D., Jaquinod M.et al. Structural analysis of the heparin-binding site of the NC1 domain of collagen XIV by CD and NMR. Biochemistry. 38:1999;6479-6488.
26. Olson S.T., Halvorson H.R., Bjork I. Quantitative characterization of the thrombin-heparin interaction. Discrimination between specific and non-specific binding models. J. Biol. Chem. 266:1991;6342-6352.
27. Pankhurst G.J., Bennett C.A., Easterbrook-Smith S.M. Characterization of the heparin-binding properties of human clusterin. Biochemistry. 37:1998;4823-4830.
28. Patel H.V., Vyas A.A., Vyas K.A., Liu Y.-S., Chiang C.-M., Chi L.M.et al. Heparin and heparan sulfate bind to snake cardiotoxin-sulfated oligosaccharide as a potential target of cardiotoxin action. J. Biol. Chem. 272:1997;1484-1492.
29. Pease J.H.B., Wemmer D.E. Solution structure of apamin determined by nuclear magnetic resonance and distance geometry. Biochemistry. 27:1988;8491-8498.
30. Piotto M., Saudek V., Sklenar V. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J. Biomol. NMR. 2:1992;661-666.
31. Rezaie A.R. Identification of basic residues in the heparin-binding exosite of factor Xa critical for heparin and factor Va binding. J. Biol. Chem. 275:2000;3320-3327.
32. Sobel M., Soler D.F., Kermode J.C., Harris R.B. Localization and characterization of a heparin binding domain peptide of human von Willebrand factor. J. Biol. Chem. 267:1992;8857-8862.
33. Spillmann D., Lindahl U. Glycosaminoglycan-protein interactions: a question of specificity. Curr. Opin. Struct. Biol. 4:1994;677-682.
34. Verrecchio A., Germann M.W., Schick B., Kung B., Twardowski T., San Antonio J.D. Design of peptides with high affinities for heparin and endothelial cell proteoglycan. J. Biol. Chem. 275:2000;7701-7707.
35. Walker A., Turnbull J.E., Gallagher J.T. Specific heparan sulfate saccharides mediate the activity of basic fibroblast growth factor. J. Biol. Chem. 269:1994;931-935.
36. Yanagishita M., Hascall V.C. Cell surface heparan sulfate proteoglycans. J. Biol. Chem. 267:1992;9451-9454.